Websters 6 in 1 B12 Vaccine

Kraj: Australia

Język: angielski

Źródło: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Składnik aktywny:

HYDROXOCOBALAMIN ACETATE; CLOSTRIDIUM CHAUVOEI ANACULTURE; CORYNEBACTERIUM PSEUDOTUBERCULOSIS (OVIS) ANACULTURE; CLOSTRIDIUM NOVYI TYPE B - TOXOID; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID; CLOSTRIDIUM SEPTICUM - TOXOID; CLOSTRIDIUM TETANI - TOXOID; THIOMERSAL

Dostępny od:

VIRBAC (AUSTRALIA) PTY LTD

Forma farmaceutyczna:

MISC. VACCINES OR ANTI SERA

Skład:

HYDROXOCOBALAMIN ACETATE VITAMIN-B12 Active 2.0 mg/ml; CLOSTRIDIUM CHAUVOEI ANACULTURE VACCINE-MICROBIAL Active 0.3 pcv/mL; CORYNEBACTERIUM PSEUDOTUBERCULOSIS (OVIS) ANACULTURE VACCINE Active 0.05 units/ml; CLOSTRIDIUM NOVYI TYPE B - TOXOID VACCINE-TOXOID Active 6.0 CPU/ml; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID VACCINE-TOXOID Active 30.0 CPU/ml; CLOSTRIDIUM SEPTICUM - TOXOID VACCINE-TOXOID Active 8.0 CPU/ml; CLOSTRIDIUM TETANI - TOXOID VACCINE-TOXOID Active 3.0 Lf/mL; THIOMERSAL MERCURY Other 0.13 mg/ml

Sztuk w opakowaniu:

100mL; 200mL; 500mL; 50mL

Klasa:

VM - Veterinary Medicine

Dziedzina terapeutyczna:

IMMUNOTHERAPY

Podsumowanie produktu:

Poison schedule: 0; Withholding period: Zero (0) Days Zero (0) Days; Host/pest details: LAMB: [BLACK DISEASE, BLACKLEG, CASEOUS LYMPHADENITIS (CHEESY GLAND), ENTEROTOXAEMIA (PULPY KIDNEY), MALIGNANT OEDEMA, TETANUS]; SHEEP: [BLACK DISEASE, BLACKLEG, CASEOUS LYMPHADENITIS (CHEESY GLAND), ENTEROTOXAEMIA (PULPY KIDNEY), MALIGNANT OEDEMA, TETANUS, VITAMIN B12 DEFICIENCY]

Status autoryzacji:

Registered

Data autoryzacji:

2023-07-01

Ulotka dla pacjenta

Product Name:
APVMA Approval No:
Websters 6 in 1 B12 Vaccine
88864/122698
Label Name:
Websters 6 in 1 B12 Vaccine
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Contains aluminium adjuvanted toxoid and cellular antigen from
Corynebacterium
pseudotuberculosis (ovis) 1.0 U/mL, Clostridium perfringens type D 5.0
IU/mL, Cl. novyi
type B 3.5 IU/mL, Cl. tetani 2.5 IU/mL, Cl. septicum 2.5 IU/mL, Cl.
chauvoei ≥ 0.3% PCV/
mL and Vitamin B12 (hydroxocobalamin acetate) 2 mg/mL.
0.13 mg/mL of thiomersal added as a preservative
Claims:
For the prevention of cheesy gland (C. pseudotuberculosis), pulpy
kidney (Cl. perfringens
type D), black disease (Cl. novyi type B), malignant oedema (Cl.
septicum), tetanus (Cl.
tetani) and blackleg (Cl. chauvoei) in sheep and lambs.
For the treatment and prevention of vitamin B12 deficiency in sheep in
areas known or
suspected to be cobalt deficient.
Net Contents:
50mL, 100mL, 200mL, 500mL
Directions for Use:
Restraints:
Contraindications:
Precautions:
Side Effects:
Dosage and
Administration:
Shake well before use and keep thoroughly mixed during use.
Use the contents within 50 days of first broaching the pack.
Discard the unused portion.
Handle aseptically and follow resealing and storage instructions RLP APPROVED
Dosage: 1 mL dose by subcutaneous injection (under the skin, NOT into
the muscle).
Lambs: 1 mL dose at marking followed by a second 1 mL dose 4 to 6
weeks later. An
annual booster dose will maintain a high level of immunity.
Ewes (fully vaccinated as lambs): 1mL annual booster dose. Administer
2 to 3 weeks
before lambing if possible. This will ensure that high levels of
protective antibodies are
passed to the lambs in colostrum to protect them in their first 6
weeks of life and at marking.
Slaughter lambs from vaccinated ewes: 1 mL dose at marking. This will
usually be sufficient
to protect prime lambs from vaccinated ewes going to early slaughter.
Unvaccinated rams, ewes and wethers: all unvaccinated sheep introduced
onto a property
should be vaccinated with